Key result
Carotid artery stenting has shown safety, feasibility, and equivalence to carotid endarterectomy in intermediate to high surgical risk patients, despite ongoing controversies.
This review summarizes the evolution, safety, and ongoing controversies of carotid artery stenting compared to carotid endarterectomy.
Supports CAS in select high-risk patients; leaves open optimal selection and long-term outcomes amid controversies.
Surgical options developed to treat carotid artery stenosis have evolved in the last six decades, and studies have shown the superiority of carotid endarterectomy (CEA) compared to medical therapy. Similarly, as endovascular therapy has evolved over the last two decades, studies reflecting safety, feasibility, and equivalence of carotid artery stenting (CAS) to CEA have been replicated in several studies for intermediate to high surgical risk patients. However, since its inception, the field of CAS has been mired in several controversies and has been subject to intense scrutiny from multiple stakeholders within the field of medicine. This review discusses specific issues concerning CAS that are relevant in the current era.
No takes yet. Share an insight, caveat, or question.
Wayangankar et al. (2016) conducted a review in Carotid artery stenosis. Carotid artery stenting (CAS) vs. Carotid endarterectomy (CEA) was evaluated. Carotid artery stenting has shown safety, feasibility, and equivalence to carotid endarterectomy in intermediate to high surgical risk patients, despite ongoing controversies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: